Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05846659
Title Study of PULSAR-ICI +/- IMSA101 in Patients With Oligoprogressive Solid Tumor Malignancies
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors ImmuneSensor Therapeutics Inc.
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.